DEveloping BBB-ASL as non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD): Study design

Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy an...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cerebral circulation - cognition and behavior Ročník 6; s. 100308
Hlavní autori: Padrela, Beatriz, Mahroo, Amnah, Tee, Mervin, Sneve, Markus, Moyaert, Paulien, Geier, Oliver, Kuijer, Joost, Beun, Soetkin, Nordhøy, Wibeke, Zhu, Yufei David, Buck, Mareike, Hoinkiss, Daniel, Konstandin, Simon, Huber, Jörn, Wiersinga, Julia, Rikken, Roos, de Leeuw, Diederick, Grydeland, Håkon, Tippett, Lynette, Cawston, Erin, Ozturk-Isik, Esin, Linn, Jennifer, Brandt, Moritz, Tijms, Betty, van de Giessen, Elsmarieke, Muller, Majon, Fjell, Anders, Walhovd, Kristine, Pålhaugen, Lene, Selnes, Per, Clement, Patricia, Achten, Eric, Anazodo, Udunna, Barkhof, Frederik, Hilal, Saima, Fladby, Tormod, Eickel, Klaus, Morgan, Catherine, Thomas, David, Petr, Jan, Günther, Matthias, Mutsaerts, Henk J.M.M.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Elsevier B.V 2024
Elsevier
ISSN:2666-2450, 2666-2450
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy and diseased populations (Table 1) to study methodological and clinical research questions (Table 2) on the ability of BBB-ASL as an early AD biomarker. DEBBIE-AD will enroll various cohorts with subjective cognitive decline, mild cognitive impairment, and AD dementia, as well as age-matched healthy controls, at seven sites (Table 1). Our newly developed BBB-ASL sequence — implemented with the vendor-independent MRI framework gammaSTAR — will be added to multiple MRI protocols. The BBB-ASL sequence combines time-encoded multi-post labeling delay pseudo-continuous ASL with a multi-echo 3D GRASE readout, allowing estimating CBF, ATT, and the BBB time of exchange (Tex). Data analyses will be conducted using ExploreASL. Beyond MRI standard sequences, including T1w, T2w, FLAIR, DWI, the DEBBIE clinical outcomes include amyloid-PET and blood and CSF fluid biomarkers (Table 1). Preliminary testing of the BBB-ASL has been conducted on 3T systems (different Siemens Heathineers scanners) in different cohorts at multiple sites. Data processing with ExploreASL includes FSL-FABBER4 for quantification, allowing harmonized image processing. An example of the mean and standard deviation Tex maps of two DEBBIE cohorts is shown in Figure 1 to illustrate the similarities of the Tex patterns from two cohorts of similar-aged healthy adults from different sites. The DEBBIE-AD study aims to provide evidence on the ability of BBB-ASL to measure BBB permeability and demonstrate its utility in AD-related pathologies. The presented sequence may provide novel and unique insights into the staging of BBB permeability changes in groups at greater risk of developing AD, which may, in turn, provide new targets for treatment.
AbstractList Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy and diseased populations (Table 1) to study methodological and clinical research questions (Table 2) on the ability of BBB-ASL as an early AD biomarker. DEBBIE-AD will enroll various cohorts with subjective cognitive decline, mild cognitive impairment, and AD dementia, as well as age-matched healthy controls, at seven sites (Table 1). Our newly developed BBB-ASL sequence — implemented with the vendor-independent MRI framework gammaSTAR — will be added to multiple MRI protocols. The BBB-ASL sequence combines time-encoded multi-post labeling delay pseudo-continuous ASL with a multi-echo 3D GRASE readout, allowing estimating CBF, ATT, and the BBB time of exchange (Tex). Data analyses will be conducted using ExploreASL. Beyond MRI standard sequences, including T1w, T2w, FLAIR, DWI, the DEBBIE clinical outcomes include amyloid-PET and blood and CSF fluid biomarkers (Table 1). Preliminary testing of the BBB-ASL has been conducted on 3T systems (different Siemens Heathineers scanners) in different cohorts at multiple sites. Data processing with ExploreASL includes FSL-FABBER4 for quantification, allowing harmonized image processing. An example of the mean and standard deviation Tex maps of two DEBBIE cohorts is shown in Figure 1 to illustrate the similarities of the Tex patterns from two cohorts of similar-aged healthy adults from different sites. The DEBBIE-AD study aims to provide evidence on the ability of BBB-ASL to measure BBB permeability and demonstrate its utility in AD-related pathologies. The presented sequence may provide novel and unique insights into the staging of BBB permeability changes in groups at greater risk of developing AD, which may, in turn, provide new targets for treatment.
Introduction: Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD) multi-cohort study integrates this modified BBB-ASL technique in several healthy and diseased populations (Table 1) to study methodological and clinical research questions (Table 2) on the ability of BBB-ASL as an early AD biomarker. Methods: DEBBIE-AD will enroll various cohorts with subjective cognitive decline, mild cognitive impairment, and AD dementia, as well as age-matched healthy controls, at seven sites (Table 1). Our newly developed BBB-ASL sequence — implemented with the vendor-independent MRI framework gammaSTAR — will be added to multiple MRI protocols. The BBB-ASL sequence combines time-encoded multi-post labeling delay pseudo-continuous ASL with a multi-echo 3D GRASE readout, allowing estimating CBF, ATT, and the BBB time of exchange (Tex). Data analyses will be conducted using ExploreASL. Beyond MRI standard sequences, including T1w, T2w, FLAIR, DWI, the DEBBIE clinical outcomes include amyloid-PET and blood and CSF fluid biomarkers (Table 1). Expected Results: Preliminary testing of the BBB-ASL has been conducted on 3T systems (different Siemens Heathineers scanners) in different cohorts at multiple sites. Data processing with ExploreASL includes FSL-FABBER4 for quantification, allowing harmonized image processing. An example of the mean and standard deviation Tex maps of two DEBBIE cohorts is shown in Figure 1 to illustrate the similarities of the Tex patterns from two cohorts of similar-aged healthy adults from different sites. Discussion: The DEBBIE-AD study aims to provide evidence on the ability of BBB-ASL to measure BBB permeability and demonstrate its utility in AD-related pathologies. The presented sequence may provide novel and unique insights into the staging of BBB permeability changes in groups at greater risk of developing AD, which may, in turn, provide new targets for treatment.
ArticleNumber 100308
Author Petr, Jan
Mutsaerts, Henk J.M.M.
Morgan, Catherine
Pålhaugen, Lene
Linn, Jennifer
de Leeuw, Diederick
Buck, Mareike
Tijms, Betty
Moyaert, Paulien
Rikken, Roos
Fladby, Tormod
Wiersinga, Julia
Ozturk-Isik, Esin
Clement, Patricia
Padrela, Beatriz
Barkhof, Frederik
Hilal, Saima
Walhovd, Kristine
Fjell, Anders
Brandt, Moritz
Tee, Mervin
Zhu, Yufei David
Konstandin, Simon
Grydeland, Håkon
Muller, Majon
Eickel, Klaus
Sneve, Markus
Selnes, Per
Cawston, Erin
Huber, Jörn
Mahroo, Amnah
Tippett, Lynette
Achten, Eric
Nordhøy, Wibeke
Anazodo, Udunna
van de Giessen, Elsmarieke
Geier, Oliver
Günther, Matthias
Beun, Soetkin
Thomas, David
Hoinkiss, Daniel
Kuijer, Joost
Author_xml – sequence: 1
  givenname: Beatriz
  surname: Padrela
  fullname: Padrela, Beatriz
  organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands
– sequence: 2
  givenname: Amnah
  surname: Mahroo
  fullname: Mahroo, Amnah
  organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany
– sequence: 3
  givenname: Mervin
  surname: Tee
  fullname: Tee, Mervin
  organization: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore
– sequence: 4
  givenname: Markus
  surname: Sneve
  fullname: Sneve, Markus
  organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway
– sequence: 5
  givenname: Paulien
  surname: Moyaert
  fullname: Moyaert, Paulien
  organization: Lawson Health Research Institute, London, Ontario, Canada
– sequence: 6
  givenname: Oliver
  surname: Geier
  fullname: Geier, Oliver
  organization: Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway
– sequence: 7
  givenname: Joost
  surname: Kuijer
  fullname: Kuijer, Joost
  organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands
– sequence: 8
  givenname: Soetkin
  surname: Beun
  fullname: Beun, Soetkin
  organization: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
– sequence: 9
  givenname: Wibeke
  surname: Nordhøy
  fullname: Nordhøy, Wibeke
  organization: Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway
– sequence: 10
  givenname: Yufei David
  surname: Zhu
  fullname: Zhu, Yufei David
  organization: Biomedical Engineering, University of California, Davis, Davis, CA
– sequence: 11
  givenname: Mareike
  surname: Buck
  fullname: Buck, Mareike
  organization: University of Bremen, Bremen, Germany
– sequence: 12
  givenname: Daniel
  surname: Hoinkiss
  fullname: Hoinkiss, Daniel
  organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany
– sequence: 13
  givenname: Simon
  surname: Konstandin
  fullname: Konstandin, Simon
  organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany
– sequence: 14
  givenname: Jörn
  surname: Huber
  fullname: Huber, Jörn
  organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany
– sequence: 15
  givenname: Julia
  surname: Wiersinga
  fullname: Wiersinga, Julia
  organization: Department of Internal Medicine, Geriatrics Section, Amsterdam Cardiovascular Sciences Institute, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands
– sequence: 16
  givenname: Roos
  surname: Rikken
  fullname: Rikken, Roos
  organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands
– sequence: 17
  givenname: Diederick
  surname: de Leeuw
  fullname: de Leeuw, Diederick
  organization: Alzheimer Center Amsterdam, Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands
– sequence: 18
  givenname: Håkon
  surname: Grydeland
  fullname: Grydeland, Håkon
  organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway
– sequence: 19
  givenname: Lynette
  surname: Tippett
  fullname: Tippett, Lynette
  organization: University of Auckland, School of Psychology and Centre for Brain Research, Auckland, New Zealand
– sequence: 20
  givenname: Erin
  surname: Cawston
  fullname: Cawston, Erin
  organization: University of Auckland, Department of Pharmacology and Centre for Brain Research, Auckland, New Zealand
– sequence: 21
  givenname: Esin
  surname: Ozturk-Isik
  fullname: Ozturk-Isik, Esin
  organization: Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey
– sequence: 22
  givenname: Jennifer
  surname: Linn
  fullname: Linn, Jennifer
  organization: Department of Neurology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
– sequence: 23
  givenname: Moritz
  surname: Brandt
  fullname: Brandt, Moritz
  organization: Department of Neurology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
– sequence: 24
  givenname: Betty
  surname: Tijms
  fullname: Tijms, Betty
  organization: Alzheimer Center Amsterdam, Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands
– sequence: 25
  givenname: Elsmarieke
  surname: van de Giessen
  fullname: van de Giessen, Elsmarieke
  organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands
– sequence: 26
  givenname: Majon
  surname: Muller
  fullname: Muller, Majon
  organization: Department of Internal Medicine, Geriatrics Section, Amsterdam Cardiovascular Sciences Institute, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands
– sequence: 27
  givenname: Anders
  surname: Fjell
  fullname: Fjell, Anders
  organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway
– sequence: 28
  givenname: Kristine
  surname: Walhovd
  fullname: Walhovd, Kristine
  organization: Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway
– sequence: 29
  givenname: Lene
  surname: Pålhaugen
  fullname: Pålhaugen, Lene
  organization: Department of Neurology, Akershus University Hospital, Lørenskog, Norway
– sequence: 30
  givenname: Per
  surname: Selnes
  fullname: Selnes, Per
  organization: Department of Neurology, Akershus University Hospital, Lørenskog, Norway
– sequence: 31
  givenname: Patricia
  surname: Clement
  fullname: Clement, Patricia
  organization: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
– sequence: 32
  givenname: Eric
  surname: Achten
  fullname: Achten, Eric
  organization: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
– sequence: 33
  givenname: Udunna
  surname: Anazodo
  fullname: Anazodo, Udunna
  organization: Lawson Health Research Institute, London, Ontario, Canada
– sequence: 34
  givenname: Frederik
  surname: Barkhof
  fullname: Barkhof, Frederik
  organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands
– sequence: 35
  givenname: Saima
  surname: Hilal
  fullname: Hilal, Saima
  organization: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore
– sequence: 36
  givenname: Tormod
  surname: Fladby
  fullname: Fladby, Tormod
  organization: Department of Neurology, Akershus University Hospital, Lørenskog, Norway
– sequence: 37
  givenname: Klaus
  surname: Eickel
  fullname: Eickel, Klaus
  organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany
– sequence: 38
  givenname: Catherine
  surname: Morgan
  fullname: Morgan, Catherine
  organization: University of Auckland, School of Psychology and Centre for Brain Research, Auckland, New Zealand
– sequence: 39
  givenname: David
  surname: Thomas
  fullname: Thomas, David
  organization: Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, UK
– sequence: 40
  givenname: Jan
  surname: Petr
  fullname: Petr, Jan
  organization: Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany
– sequence: 41
  givenname: Matthias
  surname: Günther
  fullname: Günther, Matthias
  organization: Fraunhofer-Institute for Digital Medicine MEVIS, Bremen, Germany
– sequence: 42
  givenname: Henk J.M.M.
  surname: Mutsaerts
  fullname: Mutsaerts, Henk J.M.M.
  organization: Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands
BookMark eNp9kEFvEzEQhS1UJErpH-DkW8thw9jr9Tqol2yzQKRIHApny54dB6fb3cpOI6W_ng1BVU-cZvSk982b956dDeNAjH0UMBMg9OftDBH9TIJUkwAlmDfsXGqtC6kqOHu1v2OXOW8BQFZCmFKcM1y2e-rHxzhseNM0xeJuzV3m04ViNexdjnvirUv9gfs4Prh0T4mPgS_6598UHyhdZb6MmVwmfr1sm2bVFovlpy_8bvfUHXhHOW6GD-xtcH2my3_zgv362v68_V6sf3xb3S7WBUrQplCOyFcdelUKD8aZem6qTjqoahOEAE11p2VXhgq9lEZICIgGSsR5mGtvygu2OnG70W3tY4pT3oMdXbR_hTFtrEu7iD3ZMCeFoVRGBa8qXTs3MYLxAmQtScHEkicWpjHnROGFJ8AeW7dbe2zdHlu3p9Yn083JRNOX-0jJZow0IHUxEe6mGPF_9j9QJIl_
ContentType Journal Article
Copyright 2024
Copyright_xml – notice: 2024
DBID 6I.
AAFTH
AAYXX
CITATION
DOA
DOI 10.1016/j.cccb.2024.100308
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2666-2450
ExternalDocumentID oai_doaj_org_article_f9e4cf3484fb4567aa9f9f8b10272e40
10_1016_j_cccb_2024_100308
S2666245024001090
GroupedDBID .1-
.FO
0R~
0SF
1P~
6I.
AAEDW
AAFTH
AALRI
AAXUO
ADVLN
AFRHN
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
EBS
FDB
GROUPED_DOAJ
RPM
Z5R
AAYWO
AAYXX
AFJKZ
APXCP
CITATION
ID FETCH-LOGICAL-c2068-4aeeb5dcb431b08a87985d2a0578f1106e7d62d3f5cb228120fcc803cc9f96b83
IEDL.DBID DOA
ISSN 2666-2450
IngestDate Fri Oct 03 12:43:50 EDT 2025
Sat Nov 29 02:23:43 EST 2025
Sat Sep 07 15:50:49 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2068-4aeeb5dcb431b08a87985d2a0578f1106e7d62d3f5cb228120fcc803cc9f96b83
OpenAccessLink https://doaj.org/article/f9e4cf3484fb4567aa9f9f8b10272e40
ParticipantIDs doaj_primary_oai_doaj_org_article_f9e4cf3484fb4567aa9f9f8b10272e40
crossref_primary_10_1016_j_cccb_2024_100308
elsevier_sciencedirect_doi_10_1016_j_cccb_2024_100308
PublicationCentury 2000
PublicationDate 2024
2024-00-00
2024-01-01
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024
PublicationDecade 2020
PublicationTitle Cerebral circulation - cognition and behavior
PublicationYear 2024
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
SSID ssj0002511831
Score 2.242238
Snippet Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as a...
Introduction: Arterial spin labeling (ASL) MRI, a non-invasive technique for imaging perfusion, now allows studying BBB permeability. The DEveloping BBB-ASL as...
SourceID doaj
crossref
elsevier
SourceType Open Website
Index Database
Publisher
StartPage 100308
Title DEveloping BBB-ASL as non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD): Study design
URI https://dx.doi.org/10.1016/j.cccb.2024.100308
https://doaj.org/article/f9e4cf3484fb4567aa9f9f8b10272e40
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2666-2450
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511831
  issn: 2666-2450
  databaseCode: DOA
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS8MwFA4iHryIouL8RQ6CigS7JG1Tb5vdUBhDUGG3kp840SndHOhf70vTSk968VZKScL3Qr_32u99QegkdanLhMyI5TIinDpDYCtb74yoDEsYS6OqUXiUjsdiMsnuWkd9eU1YsAcOwF26zHLtGBfcKSD7VMrMZU4oIMaUWl5V65D1tIop_w6uEmfWrbtkgqBLa62gIKTcKwOYP0-yxUSVYX-LkFokM9xEG3V2iHthVVtoxc62kc4HTWMT7vf7pHc_wnKOoW4nt7Ol9PpzXPkUY99L7-U2JX5zuPfy9WSnr7Y8neM8_IbBZ_kA6t4B6eXnV9hLCD-xqSQcO-hxOHi4viH12QhE0ygRhEtrVWy0ggRARUKKNBOxoRLSL-GA0hObmoQa5mKtKAUWj5zWImJaA3yJEmwXrcI67R7CsaNKwghKG8HjroEr7_FiYmFFZIzpoIsGp-I9WGAUjTbsufCoFh7VIqDaQX0P5c-T3r66ugFBLeqgFn8FtYPiJhBFnQkEhoehpr9Mvv8fkx-gdT9k-M5yiFYX5Yc9Qmt6uZjOy-Nqn30DVQPVLg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DEveloping+BBB-ASL+as+non-Invasive+Early+biomarker+of+Alzheimer%27s+Disease+%28DEBBIE-AD%29%3A+Study+design&rft.jtitle=Cerebral+circulation+-+cognition+and+behavior&rft.au=Padrela%2C+Beatriz&rft.au=Mahroo%2C+Amnah&rft.au=Tee%2C+Mervin&rft.au=Sneve%2C+Markus&rft.date=2024&rft.issn=2666-2450&rft.eissn=2666-2450&rft.volume=6&rft.spage=100308&rft_id=info:doi/10.1016%2Fj.cccb.2024.100308&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_cccb_2024_100308
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2666-2450&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2666-2450&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2666-2450&client=summon